Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.14% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTVA
2751
MetaVia Inc
MTVA
$7.44M
| $526K | ﹤0.01% |
+1
| New | +$725K |
|
|
ARCW
2752
DELISTED
ARC Group Worldwide, Inc
ARCW
| $525K | ﹤0.01% |
186,300
+4,980
| +3% | +$17.5K |
|
2753
VanEck Gold Miners ETF
GDX
$22.7B
| $523K | ﹤0.01% |
23,700
-40,500
| -63% | -$921K |
|
|
ASBB
2754
DELISTED
ASB Bancorp Inc
ASBB
| $523K | ﹤0.01% |
+11,900
| New | +$480K |
|
|
FGNX
2755
FG Nexus Inc
FGNX
$38.9M
| $522K | ﹤0.01% |
523
+101
| +24% | +$96.7K |
|
|
GFED
2756
DELISTED
Guaranty Federal Bancshares In
GFED
| $522K | ﹤0.01% |
25,800
+400
| +2% | +$7.98K |
|
|
HWCC
2757
DELISTED
Houston Wire & Cable Company
HWCC
| $521K | ﹤0.01% |
100,100
+2,700
| +3% | +$16.9K |
|
2758
Community Bank
CBU
$3.4B
| $515K | ﹤0.01% |
9,240
-66,389
| -88% | -$3.67M |
|
2759
First Bank
FRBA
$473M
| $515K | ﹤0.01% |
44,200
-9,400
| -18% | -$115K |
|
|
AATC
2760
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
| $515K | ﹤0.01% |
143,100
-12,400
| -8% | -$40.1K |
|
|
MBFI
2761
DELISTED
MB Financial Corp
MBFI
| $515K | ﹤0.01% |
11,700
-99,693
| -89% | -$4.25M |
|
2762
Distribution Solutions Group
DSGR
$1.6B
| $514K | ﹤0.01% |
46,400
-20,200
| -30% | -$213K |
|
2763
Suncor Energy
SU
$75.5B
| $514K | ﹤0.01% |
17,600
-240,940
| -93% | -$7.41M |
|
2764
AZZ Inc
AZZ
$4.41B
| $508K | ﹤0.01% |
+9,100
| New | +$517K |
|
2765
FS Bancorp
FSBW
$323M
| $508K | ﹤0.01% |
23,200
+5,400
| +30% | +$116K |
|
|
AXE
2766
DELISTED
Anixter International Inc
AXE
| $508K | ﹤0.01% |
+6,500
| New | +$508K |
|
2767
LGL Group
LGL
$44.4M
| $502K | ﹤0.01% |
276,073
+73,195
| +36% | +$133K |
|
2768
Norwood Financial Corp
NWFL
$372M
| $499K | ﹤0.01% |
+17,700
| New | +$467K |
|
|
ADAM
2769
Adamas Trust
ADAM
$783M
| $499K | ﹤0.01% |
+20,045
| New | +$505K |
|
2770
Global Partners
GLP
$1.64B
| $498K | ﹤0.01% |
27,600
-18,009
| -39% | -$338K |
|
2771
Curis
CRIS
$9.26M
| $495K | ﹤0.01% |
131
-43
| -25% | -$180K |
|
2772
Lisata Therapeutics
LSTA
$10.7M
| $494K | ﹤0.01% |
7,083
+580
| +9% | +$41K |
|
|
BEL
2773
DELISTED
Belmond Ltd.
BEL
| $492K | ﹤0.01% |
37,000
-382,273
| -91% | -$4.79M |
|
|
PFIE
2774
DELISTED
Profire Energy, Inc
PFIE
| $490K | ﹤0.01% |
377,200
+35,740
| +10% | +$47.8K |
|
|
DPLO
2775
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $490K | ﹤0.01% |
33,100
+5,200
| +19% | +$86.7K |
|
Similar funds
Renaissance Technologies's Q2 2017 Portfolio in Review
As of Q2 2017, Renaissance Technologies held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Renaissance Technologies deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Renaissance Technologies's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Renaissance Technologies's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Renaissance Technologies fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Renaissance Technologies's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Renaissance Technologies opened 398 new positions and closed 418 in Q2 2017.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.